Overview

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Status:
Terminated

Trial end date:
2006-05-01

Target enrollment:

Participant gender:

Summary

This multicenter trial tested whether inhaled nitric oxide would reduce death or the need for oxygen in preterm infants (less than 34 weeks gestational age) with severe lung disease.

Phase:

Phase 3

Details

Lead Sponsor:

NICHD Neonatal Research Network

Collaborator:

National Center for Research Resources (NCRR)

Treatments:

Nitric Oxide